US-based medical device innovator CapsoVision has obtained the US Food and Drug Administration (FDA) 510(k) clearance for the CapsoCam Plus small bowel capsule endoscope system.
CapsoCam Plus consists of a capsule endoscope, a retrieval kit, a data access system, and software, which work together to facilitate a streamlined, patient-friendly examination and does not require the patient to wear receiver equipment during the examination.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
The system Plus has been designed to provide a 360º panoramic lateral image of the small bowel to detect small bowel abnormalities.
The images are stored in a flash memory system within the capsule.
The in vivo images and other data are collected during a CapsoCam Plus examination, by placing the capsule into the CapsoAccess system and click download which is then accessed using CapsoView software, available for both Microsoft Windows and Mac OSX operating systems.
CapsoVision President Johnny Wang said: “Without the need for capital equipment, the barriers to entry are significantly reduced, and physicians can perform more capsule endoscopy procedures more flexibly while minimising expenses related to staffing and exam room time.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalData“In fact, last month in Europe, one of our physician panel presenters also reported reduced reading time with our new software, so the potential time-savings of a CapsoCam Plus examination are significant and extend to each aspect of the exam process.”
